Chengshui Chen
Impact in
- Cancer Research top 10%
-
- Neonatal Respiratory Health Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Neonatal Respiratory Health Research 15
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
-
- MicroRNA in disease regulation 6
- Cancer Genomics and Diagnostics 5
- Co-authors
- Xiangdong Wang (12 shared papers)Lin Shi (5 shared papers)Nian Dong (11 shared papers)Xiangdong Wang (8 shared papers)Yuping Li (12 shared papers)Savério Bellusci (16 shared papers)Jin‐San Zhang (17 shared papers)Shuanying Yang (1 shared paper)
- Journals
- Cell Biology and Toxicology (5 papers)Clinical and Translational Medicine (5 papers)Journal of Cellular and Molecular Medicine (4 papers)International Immunopharmacology (4 papers)Frontiers in Cell and Developmental Biology (4 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Chengshui Chen
93 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 184
- Pulmonary and Respiratory Medicine 364
- Molecular Biology 690
- Immunology 155
- Infectious Diseases 128
Countries citing papers authored by Chengshui Chen
This map shows the geographic impact of Chengshui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengshui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengshui Chen more than expected).
Fields of papers citing papers by Chengshui Chen
This network shows the impact of papers produced by Chengshui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengshui Chen. The network helps show where Chengshui Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengshui Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 186 | |
| 2 | 2016 | 86 | |
| 3 | 2016 | 73 | |
| 4 | 2014 | 69 | |
| 5 | 2014 | 56 | |
| 6 | 2013 | 51 | |
| 7 | 2020 | 47 | |
| 8 | 2016 | 45 | |
| 9 | 2015 | 44 | |
| 10 | Thalidomide Combined with Low-dose Glucocorticoid in the Treatment of COVID-19 Pneumonia | 2020 | 37 |
| 11 | 2017 | 35 | |
| 12 | 2019 | 35 | |
| 13 | 2019 | 33 | |
| 14 | 2020 | 31 | |
| 15 | 2014 | 31 | |
| 16 | 2020 | 28 | |
| 17 | 2014 | 28 | |
| 18 | 2022 | 26 | |
| 19 | 2020 | 26 | |
| 20 | 2024 | 25 |
About Chengshui Chen
Chengshui Chen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Immunology and Surgery, having authored 100 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (15 papers), Fibroblast Growth Factor Research (9 papers), Congenital Diaphragmatic Hernia Studies (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), MicroRNA in disease regulation (6 papers), COVID-19 Clinical Research Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Cancer Research (184 citations), Pulmonary and Respiratory Medicine (364 citations), Molecular Biology (690 citations), Immunology (155 citations) and Infectious Diseases (128 citations). Chengshui Chen has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Xiangdong Wang, Lin Shi, Nian Dong, Xiangdong Wang, Yuping Li, Savério Bellusci, Jin‐San Zhang, Shuanying Yang, Xiaokun Li and Chunxue Bai. Their work appears in journals such as Cell Biology and Toxicology, Clinical and Translational Medicine, Journal of Cellular and Molecular Medicine, International Immunopharmacology and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.